Login to Your Account



Aslan kicks off IPO on Taipei Exchange with public auction

By Chris Horton
Staff Writer

Wednesday, May 17, 2017

TAIPEI, Taiwan – Aslan Pharmaceuticals Pte. Ltd., a Singapore-based company focused on the development of treatments for prevalent tumor types in Asia, is conducting a competitive auction and public offer of common shares for its initial listing on the Taipei Exchange (TPEx).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription